GeNeuro is a Switzerland-based biopharmaceutical company that researches and develops novel therapies for the treatment of neurodegenerative diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address: 3, Chemin du Pre-Fleuri
City: Plan-les-Ouates
State: geneva
Zip: 1228
Country: CH
GeNeuro is a Switzerland-based biopharmaceutical company that researches and develops novel therapies for the treatment of neurodegenerative diseases.
Contact Phone:
Contact Email:
Listed Exchange:
PA
IPO Date:
4/15/2016
Ticker Symbol:
GNRO
Amount Raised:
$37M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2008 | Venture Round | 1 | - |
Eclosion SA Eclosion SA |
5/2022 | Post-IPO Equity | $0 |
Institut Merieux Invesco Institut Merieux Invesco |
7/2021 | Post-IPO Equity | $7.1M | 4/2016 | IPO | $37.4M | 7/2021 | Private Placement | $7.1M | 12/2021 | Grant | 1 | $7.3M |
Federal Office of Public Health (FOPH) Switzerland Federal Office of Public Health (FOPH) Switzerland |
12/2015 | Equity | - | 5/2022 | Private Placement | $8.1M | 1/2020 | Private Placement | $19.3M | 1/2020 | Post-IPO Equity | $19.4M | 12/2015 | Equity | - |
Servier Servier |
5/2022 | Post-IPO Equity | 2 | $8M |
Institut Merieux Invesco Institut Merieux Invesco |
8/2008 | Venture Round | 1 | - |
Eclosion SA Eclosion SA |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|